Arkolith/Insider Trading/TRDA/Form 4

Zeiher Bernhardt G

DirectorEntrada Therapeutics, Inc. (TRDA) · full profile →Form 4 · filed May 21, 2026
Net Buying
Open-Market Buys
$29K
Open-Market Sells
$0
Net Open-Market Flow
$29K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 20, 2026Buy(P)5K$5.86$29K5K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001689375-26-000030) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML